全身計測法
|
生物鑑定法
|
(1) 可直接自體外計測體內所含核種及活度
|
(1) 藉分析人體的排泄物間接推算體內劑量
|
(2) 可自體外直接測到體內所含核種的位置
|
(2) 必須要具備核種體內排泄常數
|
(3) 接受檢查人員必須到特定的計測室
|
(3) 分析試樣的收集較麻煩
|
(4) 對體內污染x或加馬核種的測量甚為方便，高能量貝他核種也可能測量
|
(4) 可以測量阿伐、貝他、加馬等任何核種
|
(5) 設備比較昂貴
|
(5) 可以在一般設備的實驗室度量
|
(6) 評估體內曝露劑量較正確
|
(6) 推算體內曝露結果誤差稍大
|
員級
|
師級
|
|||||||||||
921~962員
|
971~1012員
|
921~1012員
|
921~962師
|
971~1012師
|
921~1012師
|
|||||||
3-1 原子物理(atomphysics)
|
18
|
14.17%
|
32
|
15.17%
|
50
|
14.79%
|
10
|
7.94%
|
45
|
21.33%
|
55
|
16.32%
|
3-2 活度(activity)
|
11
|
8.66%
|
24
|
11.37%
|
35
|
10.36%
|
8
|
6.35%
|
15
|
7.11%
|
23
|
6.82%
|
3-3 連續衰變與中子活化(seriesdecay)
|
6
|
4.72%
|
9
|
4.27%
|
15
|
4.44%
|
9
|
7.14%
|
13
|
6.16%
|
22
|
6.53%
|
3-4 荷電粒子與物質的作用(chargedmatter)
|
4
|
3.15%
|
4
|
1.90%
|
8
|
2.37%
|
10
|
7.94%
|
5
|
2.37%
|
15
|
4.45%
|
3-5 光子與物質的作用(photonmatter)
|
10
|
7.87%
|
30
|
14.22%
|
40
|
11.83%
|
10
|
7.94%
|
28
|
13.27%
|
38
|
11.28%
|
3-6 通量、能量通量與暴露(energyfluencerate)
|
0
|
0.00%
|
8
|
3.79%
|
8
|
2.37%
|
6
|
4.76%
|
11
|
5.21%
|
17
|
5.04%
|
3
|
4
|
3.15%
|
4
|
1.90%
|
8
|
2.37%
|
13
|
10.32%
|
8
|
3.79%
|
21
|
6.23%
|
3-8 暴露率常數與增建因數(Gamma&B)
|
8
|
6.30%
|
16
|
7.58%
|
24
|
7.10%
|
1
|
0.79%
|
8
|
3.79%
|
9
|
2.67%
|
3-9 X光機防護屏蔽(xtubeshield)
|
13
|
10.24%
|
11
|
5.21%
|
24
|
7.10%
|
10
|
7.94%
|
7
|
3.32%
|
17
|
5.04%
|
3-10 劑量限制(doselimit)
|
29
|
22.83%
|
29
|
13.74%
|
58
|
17.16%
|
21
|
16.60%
|
35
|
16.59%
|
56
|
16.62%
|
3-11 ALI與DAC
|
4
|
3.15%
|
1
|
0.47%
|
5
|
1.48%
|
4
|
3.17%
|
1
|
0.47%
|
5
|
1.48%
|
3-12 輻射計測與統計(detectstatistics)
|
13
|
10.24%
|
32
|
15.17%
|
45
|
13.31%
|
19
|
15.08%
|
25
|
11.85%
|
44
|
13.06%
|
3-13有效半化期與體內劑量(internaldose)
|
7
|
5.51%
|
11
|
5.21%
|
18
|
5.33%
|
2
|
1.59%
|
8
|
3.79%
|
10
|
2.97%
|
3-14 MIRD法(MIRD)
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
1
|
0.79%
|
0
|
0.00%
|
1
|
0.30%
|
3-15 腸胃道與呼吸道模式(gitract)
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
2
|
1.50%
|
2
|
0.95%
|
4
|
1.19%
|
3-16 其他(others)
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
輻射安全-新增資料(add)
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
合計
|
127
|
100.00%
|
211
|
100.00%
|
338
|
100.00%
|
126
|
100.00%
|
211
|
100.00%
|
337
|
100.00%
|
全部(師+員)
|
||||||
921~962
|
971~1012
|
921~1012
|
||||
3-1 原子物理(atomphysics)
|
28
|
11.07%
|
77
|
18.25%
|
105
|
15.56%
|
3-2 活度(activity)
|
19
|
7.51%
|
39
|
9.24%
|
58
|
8.59%
|
3-3 連續衰變與中子活化(seriesdecay)
|
15
|
5.93%
|
22
|
5.21%
|
37
|
5.48%
|
3-4 荷電粒子與物質的作用(chargedmatter)
|
14
|
5.53%
|
9
|
2.13%
|
23
|
3.41%
|
3-5 光子與物質的作用(photonmatter)
|
20
|
7.91%
|
58
|
13.74%
|
78
|
11.56%
|
3-6 通量、能量通量與暴露(energyfluencerate)
|
6
|
2.37%
|
19
|
4.50%
|
25
|
3.70%
|
3
|
17
|
6.72%
|
12
|
2.84%
|
29
|
4.30%
|
3-8 暴露率常數與增建因數(Gamma&B)
|
9
|
3.56%
|
24
|
5.69%
|
33
|
5.89%
|
3-9 X光機防護屏蔽(xtubeshield)
|
23
|
9.09%
|
18
|
4.27%
|
41
|
6.07%
|
3-10 劑量限制(doselimit)
|
50
|
19.70%
|
64
|
15.17%
|
114
|
16.89%
|
3-11 ALI與DAC
|
8
|
3.16%
|
2
|
0.47%
|
10
|
1.48%
|
3-12 輻射計測與統計(detectstatistics)
|
32
|
12.65%
|
57
|
13.51%
|
89
|
13.19%
|
3-13有效半化期與體內劑量(internaldose)
|
9
|
3.56%
|
19
|
4.50%
|
28
|
4.15%
|
3-14 MIRD法(MIRD)
|
1
|
0.40%
|
0
|
0.00%
|
1
|
0.15%
|
3-15 腸胃道與呼吸道模式(gitract)
|
2
|
0.79%
|
2
|
0.47%
|
4
|
0.59%
|
3-16 其他(others)
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
輻射安全-新增資料(add)
|
0
|
0.00%
|
0
|
0.00%
|
0
|
0.00%
|
合計
|
253
|
100.00%
|
422
|
100.00%
|
675
|
100.00%
|
